Holmium laser enucleation of the prostate versus transurethral resection of the prostate for benign prostatic hyperplasia: evidence from a Korean retrospective analysis using the Common Data Model
Abstract
Background The aim of this study was to evaluate and compare the efficacy and safety of transurethral resection of the prostate (TURP) and holmium laser enucleation of the prostate (HoLEP) for treating benign prostatic hyperplasia using standardized multicenter data. Materials and methods We retrospectively collected data from six Korean hospitals using the Common Data Model and performed a meta-analysis. Patients were categorized into TURP (control) and HoLEP (experimental) groups, and risk ratios were calculated to compare postoperative outcomes and complications. Sensitivity analyses were conducted by sequentially excluding each hospital’s data to assess the robustness of the findings. Results HoLEP was associated with significantly lower reoperation and transfusion rates, as well as reduced postoperative use of medications (including alpha-blockers and 5-alpha reductase inhibitors), compared to TURP. Conversely, beta-3 agonist usage was notably higher in the HoLEP group, suggesting the need for further investigation in this area. Sensitivity analyses confirmed that the overall results remained robust across individual hospital exclusions. Conclusions The meta-analysis demonstrates that HoLEP offers superior efficacy and safety over TURP for benign prostatic hyperplasia treatment, particularly by reducing reoperation and transfusion rates and lowering long-term medication dependency. These findings support the clinical adoption of HoLEP as a viable alternative to TURP,…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.